Treatment of Post-partum Depression Using an Behavioral Intervention Called ROSE (Reach Out, Stay Strong, Essentials for Mothers of Newborns) Delivered Using an Electronic App
Key facts
- Who runs it
- University of Rochester
- Where
- Rochester, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 152 people enrolled
- Started
- 17 Jul 2023
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- InBloom
- ROSE
- Record updated
- 9 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- 17-32 weeks pregnant
- enrolled for prenatal care in one of the five identified practices
- English speaking
- able to use an app (audio/visual/dexterity)
- have one or more of the following PPD risk factors: Medicaid eligible; anxiety (GAD-7 > 10) during pregnancy; mild to moderate depressive symptoms (PHQ-9 = 10-19); self-reported history of depression treatment; gestational diabetes; and/or young age (18-21 years)
Who cannot take part
- demonstrate significant cognitive impairment
- younger than age 18
- patients with acute mental health needs
- cannot communicate in English
- are planning to place the child for adoption
- PHQ-9 depression score > 19
Where in United States
- University of Rochester Medical CenterRochester, United States
About the trial
What the trial wants to find out
A randomized trial of pregnant people at risk for postpartum depression comparing the InBloom app (n = 76) to ROSE (n = 76; weekly scheduled group), and two control groups. We will assess Depression at baseline and 1, 2 and 3 months, ROI at 3 months, Satisfaction at 1 and 3 months and Perceived Access at 1 and 3 months. Subject participation will last up to 8 months (minimum 17 weeks pregnant through 3 months postpartum).
The 4 groups in the trial
- women receiving InBloom appTreatment being tested
Treatment: InBloom
- women receiving ROSE as usualExisting treatment, for comparison
Treatment: ROSE
- historical controls- no treatmentNo study treatment, for comparison
We will capitalize on data from a large ROSE trial which consists of a demographically similar sample by comparing depression diagnosis outcomes for Inbloom and ROSE to the 96 participants in the care as usual group (an educational pamphlet on PPD).
- electronic health record utilization dataNo study treatment, for comparison
We will leverage EHR utilization data by retrospectively identifying 152 people from the same clinics who did not receive ROSE or InBloom and matched for eligibility criteria, demographics and PPD risk factors using propensity scores, and comparing their utilization to those in the ROSE and InBloom groups.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- InBloom App vs ROSE Outcomes and Mechanisms
- Publications
- Randomized clinical trial protocol of an app-based intervention to prevent postpartum depression.Contemporary clinical trials, 2025
- Record updated
- 9 February 2026